X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
With this funding, VLPT aims to further accelerate the research and development of a cancer treatment vaccine as well as prophylactic vaccines including VLPM01, against malaria, dengue, etc. and move into clinical trials at the earliest date possible.
Lead Product(s): VLPM01
Therapeutic Area: Infections and Infectious Diseases Product Name: VLPM01
Highest Development Status: Phase IProduct Type: Vaccine
Partner/Sponsor/Collaborator: Nobelpharma
Deal Size: $21.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing December 27, 2021
Details:
Fujifilm will utilize its manufacturing facilities and infrastructure for lipid nanoparticle to handle operations relating to VLP Therapeutics' COVID-19 vaccine formulations, from process development to manufacturing for clinical trials.
Lead Product(s): COVID 19 vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: UndisclosedProduct Type: Vaccine
Recipient: Fujifilm holding
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement October 01, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
